RSS

contract development and manufacturing organisation (CDMO)

Contract development and manufacturing organisation (CDMO) Sterling Pharma Solutions has won a Queen’s Award for outstanding export sales. Read more

News

Bioscience company Chr. Hansen and contract manufacturer Lonza have signed a joint venture in an aim to position themselves as the leading contract development and manufacturing partner (CDMO) in the industry. Read more

News

Contract development and manufacturing organisation (CDMO) Particle Sciences has launched a new active pharmaceutical ingredient (API) screening programme in order to strengthen its nanomilling offering. Read more

News

Contract development and manufacturing organisation (CDMO) The Almac Group has announced it is expanding its Edinburgh Technopole facility to help scale-up its personalised cancer vaccine activities. Read more

News

Innovate UK has awarded £1.5 million to a contract development and manufacturing organisation (CDMO) focused on advanced therapy medicinal products (ATMPs). Read more

News

Five non-critical highly potent products supplied by contract development and manufacturing organisation (CDMO) Recipharm have had their manufacturing licence restricted. Read more

News

Not all highly potent compounds require extreme containment. In this article, Jeff Pavlovich, senior process safety engineer at Cambrex Charles City, examines the intricacies of risk assessment and the importance of a realistic approach. Read more

Latest Issue

Contract development and manufacturing organisations (CDMOs) will need to invest in continuous manufacturing sooner rather than later if they are to stay competitive, a report from CPhI Worldwide has concluded. Read more

News

Manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), Cambrex, has completed its acquisition of dosage form contract development and manufacturing organisation (CDMO), Halo Pharma. Read more

News

Manufacturer of small molecule innovator and generic APIs, Cambrex, has entered into a definitive agreement to acquire Halo Pharma — a dosage form contract development and manufacturing organisation (CDMO). Read more

News

Investment-type holding company of SK Group, SK Holdings, has come to an arrangement where it will acquire 100% of the ownership interests in AMPAC Fine Chemicals (AFC) — a contract development and manufacturing organisation (CDMO). Read more

News

Contract development and manufacturing organisation (CDMO), Juniper Pharma Services, has continued its strategic capital investment with the purchase of three additional pieces of processing equipment. Read more

Technology

Contract development and manufacturing organisation (CDMO), Juniper Pharma Services, has revealed its expansion into its UK-based drug development and clinical trial manufacturing facilities. Read more

News

Minakem, the contract development and manufacturing organisation (CDMO) division of Minafin, has revealed it is in the final qualification run to open a new closed-controlled environment high containment production facility in August. Read more

News

CDMO, Recipharm, has acquired Sanofi’s manufacturing centre and business located in Holmes Chapel, which will provide the company with a platform to take advantage of the growing respiratory drug market. Read more

News

Vetter, has launched its Open Innovation Challenge campaign, aimed at developing innovative, future-focused and sustainable solutions for the injection of medicines that are better streamlined to user needs than current methods. Read more

News

ADC Biotechnology has predicted that the next crucial phase of innovation to optimise and streamline production processes of antibody drug conjugates will be designed at the clinical development stage by specialist, ADC focused service providers Read more

News

Contract development and manufacturing organisation (CDMO), Recipharm, has partnered with Hadasit Medical Research Services and Development to deliver combined clinical, biological and chemical services. Read more

News

Ardena, a contract development and manufacturing organisation (CDMO), has acquired Syntagon, a contract manufacturer of novel active pharmaceutical ingredients (APIs) and excipients. Read more

News

Contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, is investing £6 million in its pilot plant facility at its UK site for the enhancement of scale-up and small to midscale commercial API manufacturing capabilities. Read more

News